{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:02:15Z","timestamp":1791194535566,"version":"4.1.0"},"reference-count":22,"publisher":"University of Tokushima Faculty of Medicine","issue":"1,2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Invest."],"published-print":{"date-parts":[[2011]]},"DOI":"10.2152\/jmi.58.106","type":"journal-article","created":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T23:31:06Z","timestamp":1299022266000},"page":"106-109","source":"Crossref","is-referenced-by-count":36,"title":["Effect of histone deacetylase inhibitor in combination with 5-fluorouracil on pancreas cancer and cholangiocarcinoma cell lines"],"prefix":"10.2152","volume":"58","author":[{"given":"Shuichi","family":"Iwahashi","sequence":"first","affiliation":[{"name":"Department of Digestive Surgery and Transplantation, Institute of Health Biosciences, the University of Tokushima Graduate School"},{"name":"These authors equally contributed to this study."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery and Transplantation, Institute of Health Biosciences, the University of Tokushima Graduate School"},{"name":"These authors equally contributed to this study."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Utsunomiya","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery and Transplantation, Institute of Health Biosciences, the University of Tokushima Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Morine","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery and Transplantation, Institute of Health Biosciences, the University of Tokushima Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tovuu","family":"Lkhaguva Ochir","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery and Transplantation, Institute of Health Biosciences, the University of Tokushima Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hanaoka","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery and Transplantation, Institute of Health Biosciences, the University of Tokushima Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery and Transplantation, Institute of Health Biosciences, the University of Tokushima Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Ikemoto","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery and Transplantation, Institute of Health Biosciences, the University of Tokushima Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Imura","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery and Transplantation, Institute of Health Biosciences, the University of Tokushima Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery and Transplantation, Institute of Health Biosciences, the University of Tokushima Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"925","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hidalgo M: Pancreatic cancer. N Engl J Med 362: 1605-1617, 2010","DOI":"10.1056\/NEJMra0901557"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Cereda S, Passoni P, Reni M, Viganò MG, Aldrighetti L, Nicoletti R, Villa E: The cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG) regimen in advanced biliary tract adenocarcinoma. Cancer 116: 2208-14, 2010","DOI":"10.1002\/cncr.24970"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Shimada M, Sugimoto K, Iwahashi S, Utsunomiya T, Morine Y, Imura S, Ikemoto T: CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma. J Gastroenterol 45: 896-902, 2010","DOI":"10.1007\/s00535-010-0235-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Takada T, Kato H, Matsushiro T, Nimura Y, Nagakawa T, Nakayama T: Combination of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas. Oncology 51: 396-400, 1994","DOI":"10.1159\/000227373"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kajanti M, Phyronen S: Epirubicin-sequentia methotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A phase II study. Am J Clin Oncol 17: 223-226, 1994","DOI":"10.1097\/00000421-199406000-00008"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2485"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.5639"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1038\/35895"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e31815f2c2a"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Minucci S, Pelicci PG: Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 6: 38-51, 2006","DOI":"10.1038\/nrc1779"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Glozak MA, Seto E: Histone deacetylases and cancer. Oncogene 26: 5420-5432, 2007","DOI":"10.1038\/sj.onc.1210610"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.24.6969"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Xia Q, Sung J, Chowdhury W, Chen CL, Hoti N, Shabbeer S, Carducci M, Rodriguez R: Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo. Cancer Res 66: 7237-7244, 2006","DOI":"10.1158\/0008-5472.CAN-05-0487"},{"issue":"1-3","key":"14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2009.10.033","volume":"627","author":"FLIS S.","year":"2010","ISSN":"https:\/\/id.crossref.org\/issn\/0014-2999","issn-type":"print"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01559.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Warrell RP Jr, He LZ, Richon V, Calleja E, Pandolfi PP: Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst 90: 1621-1625, 1998","DOI":"10.1093\/jnci\/90.21.1621"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Blaheta RA, Michaelis M, Driever PH, Cinatl J, Jr: Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies. Med Res Rev 25: 383-397, 2005","DOI":"10.1002\/med.20027"},{"issue":"7","key":"18","first-page":"748","volume":"78","author":"TATSUMI K","year":"1987","ISSN":"https:\/\/id.crossref.org\/issn\/0910-5050","issn-type":"print"},{"issue":"11","key":"19","first-page":"2602","volume":"56","year":"1996","ISSN":"https:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199607000-00010"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Münster P, Marchion D, Bicaku E, Schmitt M, Lee JH, DeConti R, Simon G, Fishman M, Minton S, Garrett C, Chiappori A, Lush R, Sullivan D, Daud A: Phase I Trial of Histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study. J Clin Oncol 25: 1979-1985, 2007","DOI":"10.1200\/JCO.2006.08.6165"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1930"}],"container-title":["The Journal of Medical Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jmi\/58\/1,2\/58_1,2_106\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T18:08:04Z","timestamp":1621534084000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jmi\/58\/1,2\/58_1,2_106\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":22,"journal-issue":{"issue":"1,2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2152\/jmi.58.106","relation":{},"ISSN":["1343-1420","1349-6867"],"issn-type":[{"value":"1343-1420","type":"print"},{"value":"1349-6867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}